Abstract
In this issue of Blood, Speth et al identify the beneficial effects of a pharmacologic stabilizer of hypoxia-inducible factor-1a (HIF1a) for the efficient trafficking of hematopoietic stem and progenitor cells (HSPCs) to the bone marrow niche.1
Original language | English |
---|---|
Pages (from-to) | 151-152 |
Number of pages | 2 |
Journal | Blood |
Volume | 123 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2014 Jan 9 |
Externally published | Yes |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology